TotalMarketCap

Rani Therapeutics

RANINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$71.747 M

$0.51 -10.14%

Close of 6 Nov 2026

As of 6 Nov 2026, Rani Therapeutics (RANI) has a market capitalization of $71.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.63M

#3416 by revenue

Earnings

-$29.7M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #306Cumberland PharmaceuticalsCPIX$75.5M
  2. #307MedicinovaMNOV$71.9M
  3. #308Rani TherapeuticsRANI$71.7M
  4. #309Acrivon TherapeuticsACRV$67.3M
  5. #310Zhengye BiotechnologyZYBT$66.8M

What if Rani Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$202,566.87

Per share 393,563× higher

Bitcoin $1.53T

$10,960.54

Per share 21,295× higher

Apple $5.02T

$35,982.43

Per share 69,910× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Rani Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.